Targeting IL-10R: Enhancing Immune Activation in Cancer Introduction to IL-10R and Immune Suppression in CancerThe interleukin-10 receptor (IL … read more 28th Nov 2024
Enoblituzumab Biosimilar : A New Era in B7-H3-Targeted Cancer Immunotherapy Enoblituzumab is a monoclonal antibody targeting B7-H3 (CD276), a member of the B7 fam … read more 28th Nov 2024 Shanza Riaz
Siltuximab Biosimilar : Advancing IL-6 Targeted Therapies Siltuximab, a monoclonal antibody targeting interleukin-6 (IL-6), is a key therapy for … read more 28th Nov 2024 Shanza Riaz
